(106 days)
Not Found
No
The description focuses on 3D surface imaging, real-time tracking, and image processing, but does not mention AI or ML algorithms. The performance studies describe accuracy and tracking capabilities, not AI/ML specific metrics.
No.
The device is used to position and monitor patients during radiation therapy, and to withhold the beam automatically if the patient moves. It assists in treatment planning and quality assurance, but it does not directly treat or diagnose a disease or condition.
No
The AlignRT Plus system is used for patient positioning, monitoring, and beam withholding during radiation therapy. While it acquires data and assists in treatment planning and quality assurance, its primary function is not to diagnose medical conditions but rather to facilitate the delivery of a prescribed treatment.
No
The device description explicitly states that the system consists of "advanced software, a computer workstation, and one, two or three 3D camera units". It also mentions an optional "InBore camera" and a "manual head adjuster", all of which are hardware components.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens derived from the human body. The AlignRT Plus system is a surface imaging system that images the skin surface of a patient. It does not analyze blood, tissue, urine, or any other bodily fluid or substance.
- The intended use is for positioning and monitoring patients during radiation therapy. This is a clinical application directly involving the patient's physical position and movement, not the analysis of biological samples for diagnostic purposes.
- The device description clearly states it's a video-based 3D surface imaging system. This technology is used for external imaging and tracking, not for analyzing internal biological markers.
The device's function is entirely focused on external patient positioning, monitoring, and quality assurance related to radiation therapy equipment. This falls outside the scope of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The AlignRT Plus system is indicated for use to position and monitor patients relative to the prescribed treatment isocentre, and to withhold the beam automatically during radiation delivery.
For cranial treatments, a manual head adjuster is included which can be used in concert with AlignRT Plus to provide fine corrections for pitch, roll and yaw rotations.
AlignRT Plus is also used to track the patient's respiratory pattern for respiratory synchronized image acquisition, and radiation therapy treatment.
Patient contour data can be extracted and exported from the data acquired for the purpose of treatment planning.
AlignRT Plus can be calibrated directly to the treatment beam isocentre and in turn assists in performing quality assurance on MV, kV imagers, room lasers and the treatment couch.
AlignRT Plus is indicated for use during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated.
Product codes (comma separated list FDA assigned to the subject device)
IYE
Device Description
The AlignRT Plus system (K193431) is a combination of the devices AlignRT, GateCT and GateRT. A special 510(K) K193431 was submitted by Vision RT Ltd. in December 2019 and this was cleared by FDA in January 2020 for the changes and improvements made in AlignRT.
AlignRT Plus is a video-based three-dimensional (3D) surface imaging system, which is used to image the skin surface of a patient in 3D before and during radiotherapy treatment. The system consists of advanced software, a computer workstation, and one, two or three 3D camera units (each camera unit comprising a stereo pair of sensors to allow 3D surface reconstruction). The system is non-invasive, does not require the use of body markers and produces no ionizing irradiation during the imaging process.
AlignRT Plus is also able to perform both respiratory synchronised CT imaging and treatment delivery. In both instances, the system acquires a gated 3D surface model of the patient. User selected points are then tracked in real time in order to provide gating and position monitoring signals.
Real-time imaging and surface matching of the patient is possible during both setup and the treatment delivery to determine any patient movement. During treatment delivery, AlignRT Plus is also able to withhold the beam automatically, should the patient move outside user-defined tolerances.
Patient contour data may be extracted from surface data acquired by the system and exported for the purpose of treatment planning by radiotherapy professionals.
AlignRT Plus may be calibrated directly to the treatment beam isocentre using an optional custom designed calibration phantom and image processing software. It can analyse MV and kV digital imaging data acquired by other cleared devices. This in turn assists the user in performing quality assurance on MV, kV imagers, room lasers and the treatment couch.
The AlignRT Plus system includes the optional Head Adjuster for cranial treatments to allow for the manual, fine correction of pitch, roll and yaw in the patient's head position.
Precise isocenter calibration and the optional Head Adjuster provide improved frameless Stereotactic Radiosurgery (SRS). This is provided with the brand name "AlignRT SRS module".
The AlignRT Plus system is also provided under the brand OSMS (Optical Surface Monitoring System). This product is identical to AlignRT.
This 510(k) is requested for a new optional InBore camera and a change in memory size for an existing FDA 510(k) cleared product "AlignRT Plus" (K193431).
The InBore camera is optional hardware for use with bore-based linear accelerators.
The increase in memory size from 32 to 64bit increases the system's processing speed, enabling a frame rate improvement.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Video-based three-dimensional (3D) surface imaging, MV, kV digital imaging
Anatomical Site
Entire body surface.
Indicated Patient Age Range
Any individual (adult or child)
Intended User / Care Setting
Hospital and clinic environments.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Positioning accuracy: Target registration errors (as measured using calibration phantom)
§ 892.5050 Medical charged-particle radiation therapy system.
(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
March 4, 2021
Image /page/0/Picture/1 description: The image contains the logos of the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA). The HHS logo is on the left, and the FDA logo is on the right. The FDA logo includes the agency's acronym in a blue square, followed by the words "U.S. Food & Drug Administration" in blue text.
Vision RT Ltd % Jade Dunphy Regulatory Affairs Manager Dove House, Arcadia Avenue London, N3 2JU UNITED KINGDOM
Re: K203387
Trade/Device Name: AlignRT Plus Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: Class II Product Code: IYE. Dated: December 28, 2020 Received: December 28, 2020
Dear Jade Dunphy:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203387
Device Name AlignRT Plus
Indications for Use (Describe)
The AlignRT Plus system is indicated for use to position and monitor patients relative to the prescribed treatment isocentre, and to withhold the beam automatically during radiation delivery.
For cranial treatments, a manual head adjuster is included which can be used in concert with AlignRT Plus to provide fine corrections for pitch, roll and yaw rotations.
AlignRT Plus is also used to track the patient's respiratory pattern for respiratory synchronized image acquisition, and radiation therapy treatment.
Patient contour data can be extracted and exported from the data acquired for the purpose of treatment planning.
AlignRT Plus can be calibrated directly to the treatment beam isocentre and in turn assists in performing quality assurance on MV, kV imagers, room lasers and the treatment couch.
AlignRT Plus is indicated for use during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
visienrt
510(k) Premarket Notification – AlignRT v.6.4
510(k) Summary
The information below is provided for the modifications to AlignRT following the format of 21 CFR 807.92.
Submitter:
Vision RT Ltd. Dove House Arcadia Avenue London, N3 2JU United Kingdom Contact Name: Jade Dunphy Tel: +44 (0)20 8346 4300 Fax: +44 (0)20 8346 4634
Date Summary was prepared: 17 December 2020
PREDICATE DEVICE INFORMATION:
| Name of the Device: | AlignRT Plus |
|---|---|
| Premarket Notification: | K193431 |
| Trade/Proprietary Name: | AlignRT Plus (incorporating AlignRT, GateCT, GateRT), may be |
| branded as OSMS (Optical Surface Monitoring System). | |
| Manufacturer: | Vision RT Limited |
| Common or Usual Name: | Surface Guided Radio Therapy System (Patient Positioning System |
- accessory to a linear accelerator) |
| Device Class: | II |
| Classification Name: | Accessory to Medical charged-particle radiation therapy accessories,
IYE, (per 21 CFR section 892.5050) |
| Review Panel: | Radiology |
SUBJECT (MODIFIED) DEVICE:
| Name of the Device: | AlignRT Plus |
|---|---|
| Device Manufacturer: | Vision RT Limited |
| Common or Usual Name: | Surface Guided Radio Therapy System (Patient Positioning System |
| accessory to a linear accelerator) | |
| Device Class: | II |
| Classification Name: | Accessory to Medical charged-particle radiation therapy accessories, |
| IYE, (per 21 CFR section 892.5050) | |
| Review Panel: | Radiology |
4
510(k) Premarket Notification - AlignRT v.6.4
Description of Device:
The AlignRT Plus system (K193431) is a combination of the devices AlignRT, GateCT and GateRT. A special 510(K) K193431 was submitted by Vision RT Ltd. in December 2019 and this was cleared by FDA in January 2020 for the changes and improvements made in AlignRT.
AlignRT Plus is a video-based three-dimensional (3D) surface imaging system, which is used to image the skin surface of a patient in 3D before and during radiotherapy treatment. The system consists of advanced software, a computer workstation, and one, two or three 3D camera units (each camera unit comprising a stereo pair of sensors to allow 3D surface reconstruction). The system is non-invasive, does not require the use of body markers and produces no ionizing irradiation during the imaging process.
AlignRT Plus is also able to perform both respiratory synchronised CT imaging and treatment delivery. In both instances, the system acquires a gated 3D surface model of the patient. User selected points are then tracked in real time in order to provide gating and position monitoring signals.
Real-time imaging and surface matching of the patient is possible during both setup and the treatment delivery to determine any patient movement. During treatment delivery, AlignRT Plus is also able to withhold the beam automatically, should the patient move outside user-defined tolerances.
Patient contour data may be extracted from surface data acquired by the system and exported for the purpose of treatment planning by radiotherapy professionals.
AlignRT Plus may be calibrated directly to the treatment beam isocentre using an optional custom designed calibration phantom and image processing software. It can analyse MV and kV digital imaging data acquired by other cleared devices. This in turn assists the user in performing quality assurance on MV, kV imagers, room lasers and the treatment couch.
The AlignRT Plus system includes the optional Head Adjuster for cranial treatments to allow for the manual, fine correction of pitch, roll and yaw in the patient's head position.
Precise isocenter calibration and the optional Head Adjuster provide improved frameless Stereotactic Radiosurgery (SRS). This is provided with the brand name "AlignRT SRS module".
The AlignRT Plus system is also provided under the brand OSMS (Optical Surface Monitoring System). This product is identical to AlignRT.
This 510(k) is requested for a new optional InBore camera and a change in memory size for an existing FDA 510(k) cleared product "AlignRT Plus" (K193431).
The InBore camera is optional hardware for use with bore-based linear accelerators.
The increase in memory size from 32 to 64bit increases the system's processing speed, enabling a frame rate improvement.
5
510(k) Premarket Notification – AlignRT v.6.4
In line with the FDA's guidance on full disclosure, there are also minor software changes which we have evaluated as not meeting the threshold for clearance under the 510(k) programme, but which are nonetheless described in this application:
- Thermal check .
- ROI Metrics feature ●
- Hitachi, IBA and C-Series interfaces
- OPASCA lighting control system ●
- Protocol Navigator ●
- Treatment report improvement
- Surface Deformation
- QA Workflows ●
Indications for Use:
The AlignRT Plus system is indicated for use to position and monitor patients relative to the prescribed treatment isocentre, and to withhold the beam automatically during radiation delivery.
For cranial treatments, a manual head adjuster is included which can be used in concert with AlignRT Plus to provide fine corrections for pitch, roll and yaw rotations.
AlignRT Plus is also used to track the patient's respiratory pattern for respiratory synchronized image acquisition, and radiation therapy treatment.
Patient contour data can be extracted and exported from the data acquired for the purpose of treatment planning.
AlignRT Plus can be calibrated directly to the treatment beam isocentre and in turn assists in performing quality assurance on MV, kV imagers, room lasers and the treatment couch.
AlignRT Plus is indicated for use during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated.
No changes are made to the intended use and indications for use.
Summary of the Technological Characteristics:
The Substantial Equivalence Comparison Table shown provides a comparison of the technological characteristics of AlignRT Plus to those of the predicate device:
6
| PREDICATE DEVICE | MODIFIED DEVICE | COMMENTS | |
|---|---|---|---|
| Device name | AlignRT Plus (K193431) | ||
| Incorporating AlignRT, GateCT, GateRT | AlignRT Plus | ||
| Incorporating AlignRT, GateCT, GateRT | The device name is the same. | ||
| The AlignRT software application | |||
| has been up issued from v.6.2 to | |||
| v.6.4. | |||
| Manufacturer | Vision RT Ltd | Vision RT Ltd | The manufacturer has not |
| changed. | |||
| Indications for | |||
| Use | The AlignRT Plus system is indicated for use | ||
| to position and monitor patients relative to the | |||
| prescribed treatment isocenter, and to | |||
| withhold the beam automatically during | |||
| radiation delivery. |
For cranial treatments, a manual head
adjuster is included which can be used in
concert with AlignRT Plus to provide fine
corrections for pitch, roll and yaw rotations.
AlignRT Plus is also used to track the
patient's respiratory pattern for respiratory
synchronized image acquisition, and
radiation therapy treatment. Patient contour
data can be extracted and exported from the
data acquired for the purpose of treatment
planning.
AlignRT Plus can be calibrated directly to the
treatment beam isocenter and in turn assists
in performing quality assurance on MV, kV
imagers, room lasers and the treatment
couch. | The AlignRT Plus system is indicated for use
to position and monitor patients relative to the
prescribed treatment isocenter, and to
withhold the beam automatically during
radiation delivery.
For cranial treatments, a manual head
adjuster is included which can be used in
concert with AlignRT Plus to provide fine
corrections for pitch, roll and yaw rotations.
AlignRT Plus is also used to track the
patient's respiratory pattern for respiratory
synchronized image acquisition, and
radiation therapy treatment. Patient contour
data can be extracted and exported from the
data acquired for the purpose of treatment
planning.
AlignRT Plus can be calibrated directly to the
treatment beam isocenter and in turn assists
in performing quality assurance on MV, kV
imagers, room lasers and the treatment
couch. | The indications for use are the
same as those of the previously
cleared device. |
| | PREDICATE DEVICE | MODIFIED DEVICE | COMMENTS |
| | AlignRT Plus may be used during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated. | AlignRT Plus may be used during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated. | |
| Principles of operation | Video based imaging of 3D skin surface data using surface matching software. | Video based imaging of 3D skin surface data using surface matching software. | The principles of operation are the same as those of the previously cleared device. |
| Target Population | Any individual (adult or child) undergoing radiotherapy. | Any individual (adult or child) undergoing radiotherapy. | The target population is the same as that of the previously cleared device. |
| Materials | PC workstation, cables, video cameras.
Block Polystyrene (calibration phantom), carbon fibre laminate material (head adjuster). | PC workstation, cables, video cameras.
Block Polystyrene (calibration phantom), carbon fibre laminate material (head adjuster). | The materials used are the same as those of the previously cleared device. |
| System Performance and Accuracy | Positioning accuracy: Target registration errors (as measured using calibration phantom)